When comparing the transcripts of the cancer-associated RAS isoforms from embryonal development to the adult in major tissues, a clear dominance of KRAS4B expression amounting to 60–99% of all RAS transcripts was observed [66]. This evidence concerns the gene KRAS and cancer.